Senseonics Stock News

Senseonics (NYSE:SENS) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast. The Germantown, Maryland-based company posted revenues of $4 million for the three months ended Dec. 31, 2021, representing sales growth of 2.6% from the same period in 2020. Adjusted to exclude one-time items, earnings per share were 1¢, […] The post Senseonics ticks up on Q4 earnings beat appeared first on Drug Delivery Business .

These penny stocks are climbing today, here's why The post Best Penny Stocks to Buy Right Now? 4 to Watch As Stocks Turn Bullish appeared first on Penny Stocks to Buy, Picks, News and Information | Pe

Senseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Glucose monitoring system manufacturer Senseonics Holdings (SENS) swung to Q4 2021 net income amidst a modest increase in revenue.

Senseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Senseonics press release (SENS): FY GAAP EPS of -$0.72 beats by $0.22.Revenue of $13.67M beats by $0.05M.Shares -2.8%.FY 2022 Guidance: Global net revenue to Senseonics for the…

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights & Accomplishments: Received approval from the Food and Drug Administration (FDA) for the Eversense® E3 CGM System, offering patients: Fu

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q4 2021 Results - Earnings Call Transcript

Senseonics (NYSE:SENS) is scheduled to announce Q4 earnings results on Tuesday, March 1st, after market close.The consensus EPS Estimate is -$0.03 (+92.7% Y/Y) and the consensus…

AllScripts (MDRX) delivered earnings and revenue surprises of 154.84% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Fullgent Genetics (FLGT) delivered earnings and revenue surprises of 25.56% and 31.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

NEW YORK , Feb. 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLTR, M, DWAC, CSX, and SENS. Full story available on Benzinga.com

How to trade penny stocks in 2022, three things to know The post What is Affecting Penny Stocks in 2022? 3 Must-Knows For Trading appeared first on Penny Stocks to Buy, Picks, News and Information | P

How to trade penny stocks in 2022, three things to know The post What is Affecting Penny Stocks in 2022? 3 Must-Knows For Trading appeared first on Penny Stocks to Buy, Picks, News and Information | P